(Q39475300)

12 September 2017

title

The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection (English)

1 reference

12 September 2017

Onchocerca volvulus

1 reference

Soboslay PT

1

1 reference

12 September 2017

Geiger SM

2

1 reference

12 September 2017

Weiss N

3

1 reference

12 September 2017

Banla M

4

1 reference

12 September 2017

Lüder CG

5

1 reference

12 September 2017

Dreweck CM

6

1 reference

12 September 2017

Batchassi E

7

1 reference

12 September 2017

Boatin BA

8

1 reference

12 September 2017

Stadler A

9

1 reference

12 September 2017

Schulz-Key H

10

1 reference

12 September 2017

publication date

1 April 1997

1 reference

12 September 2017

1 reference

12 September 2017

volume

90

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

592-599

1 reference

Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection

12 September 2017

cites work

1 reference

12 December 2020

Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens

1 reference

12 December 2020

The Wellcome Trust Lecture. Infection and disease in lymphatic filariasis: an immunological perspective

1 reference

12 December 2020

Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment

1 reference

12 December 2020

The skin and the immune response in onchocerciasis

1 reference

12 December 2020

Distribution and severity of onchocerciasis in southern Benin, Ghana and Togo

1 reference

12 December 2020

Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients

1 reference

12 December 2020

Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset

1 reference

12 December 2020

Immunological modulation and evasion by helminth parasites in human populations

1 reference

12 December 2020

Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection

1 reference

12 December 2020

Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus

1 reference

12 December 2020

Immune responsiveness and the pathogenesis of human onchocerciasis

1 reference

12 December 2020

Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).

1 reference

12 December 2020

The presence or absence of active infection, not clinical status, is most closely associated with cytokine responses in lymphatic filariasis

1 reference

12 December 2020

Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen

1 reference

12 December 2020

Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease

1 reference

12 December 2020

Evidence for protective immunity to bancroftian filariasis in the Cook Islands

1 reference

12 December 2020

Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction.

1 reference

12 December 2020

Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man

1 reference

12 December 2020

Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals

1 reference

12 December 2020

Population dynamics of Onchocerca volvulus after 7 to 8 years of vector control in West Africa

1 reference

12 December 2020

Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area

1 reference

12 December 2020

The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa

1 reference

12 December 2020

Immunity to onchocerciasis: recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection

1 reference

12 December 2020

The profile of IgG and IgG subclasses of onchocerciasis patients

1 reference

12 December 2020

10.1046/J.1365-2567.1997.00210.X

Identifiers

DOI

1 reference

release_nmva64jor5gbjdrjm3txiktvs4

12 September 2017

Fatcat ID

0 references

PMC publication ID

1456700

0 references

1 reference